Poltreg S.A. Logo

Poltreg S.A.

ISIN

PLPLTRG00038

Ticker

PTG

Sector

Health Care

Sub-Industry

Biotechnology

Country

Poland

Year Founded

2015

About Poltreg S.A.

Company Description

Poltreg S.A. is a biotechnology company based in Poland that focuses on developing innovative therapies for autoimmune diseases. The company specializes in using T-regulatory cells (TREGs) to develop a new generation of medicines aimed at treating autoimmune diseases , such as diabetes type 1 and multiple sclerosis. Poltreg S.A. is currently conducting various stages of research and development projects in these areas to offer medical solutions to those suffering from autoimmune diseases . The company's strong commitment to research and development is reinforced by its team of qualified scientists and researchers dedicated to developing new technologies and techniques to improve health outcomes.

Served Area

Worldwide

Headquarters

Wały Piastowskie 1/Lok.1508
80-855, Gdańsk
Poland

Capital Markets Information

ISIN

PLPLTRG00038

LEI

259400XSAJTERJ42VZ86

Sub-Industry

Biotechnology

Listed Stock Exchange

Warsaw Stock Exchange

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.